Literature DB >> 17868947

The Varicella-zoster virus DNA encapsidation genes: Identification and characterization of the putative terminase subunits.

Robert J Visalli1, Denise M Nicolosi, Karen L Irven, Bradley Goshorn, Tamseel Khan, Melissa A Visalli.   

Abstract

The putative DNA encapsidation genes encoded by open reading frames (ORFs) 25, 26, 30, 34, 43, 45/42 and 54 were cloned from Varicella-zoster virus (VZV) strain Ellen. Sequencing revealed that the Ellen ORFs were highly conserved at the amino acid level when compared to those of 19 previously published VZV isolates. Additionally, RT-PCR provided the first evidence that ORF45/42 was expressed as a spliced transcript in VZV-infected cells. All seven ORFs were expressed in vitro and full length products were identified using a C-terminal V5 epitope tag. The in vitro products of the putative VZV terminase subunits encoded by ORFs 30 and 45/42 proved useful in protein-protein interaction assays. Previous studies have reported the formation of a heterodimeric terminase complex involved in DNA encapsidation for both herpes simplex virus-type 1 (HSV-1) and human cytomegalovirus (HCMV). Here we report that the C-terminal portion of exon II of ORF45/42 (ORF42-C269) interacted in GST-pull down experiments with in vitro synthesized ORF30 and ORF45/42. The interactions were maintained in the presence of anionic detergents and in buffers of increasing ionic strength. Cells transiently transfected with epitope tagged ORF45/42 or ORF30 showed primarily cytoplasmic staining. In contrast, an antiserum directed to the N-terminal portion of ORF45 showed nearly exclusive nuclear localization of the ORF45/42 gene product in infected cells. An ORF30 specific antiserum detected an 87 kDa protein in both the cytoplasmic and nuclear fractions of VZV infected cells. The results were consistent with the localization and function of herpesviral terminase subunits. This is the first study aimed at the identification and characterization of the VZV DNA encapsidation gene products.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17868947      PMCID: PMC2669082          DOI: 10.1016/j.virusres.2007.07.015

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  60 in total

1.  Herpes simplex virus UL17 protein is associated with B capsids and colocalizes with ICP35 and VP5 in infected cells.

Authors:  F Goshima; D Watanabe; H Takakuwa; K Wada; T Daikoku; M Yamada; Y Nishiyama
Journal:  Arch Virol       Date:  2000       Impact factor: 2.574

2.  Characterization of the U(L)33 gene product of herpes simplex virus 1.

Authors:  A E Reynolds; Y Fan; J D Baines
Journal:  Virology       Date:  2000-01-20       Impact factor: 3.616

Review 3.  Antivirals in the transplant setting.

Authors:  Paul D Griffiths
Journal:  Antiviral Res       Date:  2006-05-15       Impact factor: 5.970

Review 4.  Defining a role for antiviral drugs in the treatment of persons with HHV-8 infection.

Authors:  C Casper
Journal:  Herpes       Date:  2006-08

5.  Linker insertion mutations in the herpes simplex virus type 1 UL28 gene: effects on UL28 interaction with UL15 and UL33 and identification of a second-site mutation in the UL15 gene that suppresses a lethal UL28 mutation.

Authors:  Jennie G Jacobson; Kui Yang; Joel D Baines; Fred L Homa
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

6.  Putative terminase subunits of herpes simplex virus 1 form a complex in the cytoplasm and interact with portal protein in the nucleus.

Authors:  Kui Yang; Fred Homa; Joel D Baines
Journal:  J Virol       Date:  2007-03-28       Impact factor: 5.103

Review 7.  Advances in the antiviral therapy of herpes virus infection in children.

Authors:  Suzanne Luck; Mike Sharland; Paul Griffiths; Sian M Jenkins
Journal:  Expert Rev Anti Infect Ther       Date:  2006-12       Impact factor: 5.091

8.  Herpes simplex virus 1 DNA packaging proteins encoded by UL6, UL15, UL17, UL28, and UL33 are located on the external surface of the viral capsid.

Authors:  Elizabeth Wills; Luella Scholtes; Joel D Baines
Journal:  J Virol       Date:  2006-08-18       Impact factor: 5.103

Review 9.  The use of antiviral drugs in the prevention and treatment of Kaposi sarcoma, multicentric Castleman disease and primary effusion lymphoma.

Authors:  C Casper; A Wald
Journal:  Curr Top Microbiol Immunol       Date:  2007       Impact factor: 4.291

10.  Identification of the interaction domain of the small terminase subunit pUL89 with the large subunit pUL56 of human cytomegalovirus.

Authors:  Corina Thoma; Eva Borst; Martin Messerle; Manuela Rieger; Jae-Seon Hwang; Elke Bogner
Journal:  Biochemistry       Date:  2006-07-25       Impact factor: 3.162

View more
  11 in total

Review 1.  Herpesvirus Capsid Assembly and DNA Packaging.

Authors:  Jason D Heming; James F Conway; Fred L Homa
Journal:  Adv Anat Embryol Cell Biol       Date:  2017       Impact factor: 1.231

2.  The Varicella-zoster virus ORF54 gene product encodes the capsid portal protein, pORF54.

Authors:  Alexander J Howard; Debra M Sherman; Melissa A Visalli; Denise M Burnside; Robert J Visalli
Journal:  Virus Res       Date:  2012-03-28       Impact factor: 3.303

3.  Intermolecular Complementation between Two Varicella-Zoster Virus pORF30 Terminase Domains Essential for DNA Encapsidation.

Authors:  Melissa A Visalli; Brittany L House; Frances J Lahrman; Robert J Visalli
Journal:  J Virol       Date:  2015-07-22       Impact factor: 5.103

4.  Variable Gene Expression in Human Ganglia Latently Infected with Varicella-Zoster Virus.

Authors:  Peter G E Kennedy; Paul Montague
Journal:  Viruses       Date:  2022-06-09       Impact factor: 5.818

5.  The varicella-zoster virus portal protein is essential for cleavage and packaging of viral DNA.

Authors:  Melissa A Visalli; Brittany L House; Anca Selariu; Hua Zhu; Robert J Visalli
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

6.  Epstein-Barr virus BALF3 has nuclease activity and mediates mature virion production during the lytic cycle.

Authors:  Shih-Hsin Chiu; Meng-Chuan Wu; Chung-Chun Wu; Yu-Ching Chen; Su-Fang Lin; John T-A Hsu; Chung-Shi Yang; Ching-Hwa Tsai; Kenzo Takada; Mei-Ru Chen; Jen-Yang Chen
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

7.  Characterization of the Varicella-zoster virus ORF25 gene product: pORF25 interacts with multiple DNA encapsidation proteins.

Authors:  Robert J Visalli; Jacquelyn Knepper; Bradley Goshorn; Katherine Vanover; Denise M Burnside; Karen Irven; Rebecca McGauley; Melissa Visalli
Journal:  Virus Res       Date:  2009-04-07       Impact factor: 3.303

8.  Varicella zoster virus ORF25 gene product: an essential hub protein linking encapsidation proteins and the nuclear egress complex.

Authors:  Maria G Vizoso Pinto; Venkata R Pothineni; Rudolf Haase; Mathias Woidy; Amelie S Lotz-Havla; Søren W Gersting; Ania C Muntau; Jürgen Haas; Marvin Sommer; Ann M Arvin; Armin Baiker
Journal:  J Proteome Res       Date:  2011-10-26       Impact factor: 4.466

9.  Identification of a spliced gene from duck enteritis virus encoding a protein homologous to UL15 of herpes simplex virus 1.

Authors:  Hongwei Zhu; Huixin Li; Zongxi Han; Yuhao Shao; Yu Wang; Xiangang Kong
Journal:  Virol J       Date:  2011-04-06       Impact factor: 4.099

10.  Changes in subcellular localization reveal interactions between human cytomegalovirus terminase subunits.

Authors:  Jian Ben Wang; Yali Zhu; Michael A McVoy; Deborah S Parris
Journal:  Virol J       Date:  2012-12-21       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.